[Debate concerning the optimal blockage of the renin-angiotensin system].
CHU d'Amiens, Hôpital Sud - Néphrologie, Médecine Interne, Dialyse, Transplantation et Réanimation Médicale, Avenue René Laënnec-Salouël, 80054 Amiens cedex 1, France.
G
G
Choukroun
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000517:prevention & control; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007674:Kidney Diseases / Q000503:physiopathology / Q000517:prevention & control / Q000652:urine; D015201:Meta-Analysis as Topic; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D012083:Renin / Q000502:physiology; D012084:Renin-Angiotensin System / Q000187:drug effects*; D000092502:Renin Inhibitors
D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D012083:Renin; D000092502:Renin Inhibitors